Educational disclaimer. This article is published by 1836 Wellness for educational purposes only. It is not medical advice, does not diagnose or treat any condition, and does not create a doctor-patient relationship. Decisions about your health, medications, and labs should be made with a licensed clinician who knows your full history. Individual results vary.
Quick answer
Conventional lab reference ranges are statistical: they describe the middle 95% of the population that walked into the lab, not the range associated with optimal health. Because the population that walks into a lab is, on average, metabolically unwell, "normal" often means "you fit in with everyone else who feels terrible." A concierge metabolic practice compares your numbers against optimized clinical reference ranges drawn from healthy outcomes data, which is why two clinicians can look at the same blood draw and reach opposite conclusions.
The problem isn't your labs. It's the ruler.
You did everything right. You asked for a physical. You fasted overnight. You sat for the blood draw. A week later the portal lit up with a green check mark next to every value, your doctor sent a one-line message, "everything looks great," and you went back to feeling exactly the way you felt before the appointment. Tired in the afternoon. Sleeping badly. Putting on weight around the middle even though nothing about your diet has changed. Foggy by 3 p.m. Recovering more slowly from workouts than you did five years ago.
If you've had this experience, you're not imagining it. And you're not alone. It's one of the most common patterns we see in patients walking into a concierge metabolic practice for the first time.
The issue is almost never that the labs are wrong. The issue is what the labs are being compared to.
How conventional reference ranges actually get built
Most people assume a "normal" lab range represents healthy values. It doesn't. A reference range is built statistically: a large lab takes a population of patients who had blood drawn over a given window, usually a few thousand people, runs the assay, and then defines "normal" as the range that contains the middle 95% of those results. The top 2.5% and bottom 2.5% become "abnormal."
That sounds reasonable until you ask the next question: who are those thousands of people?
They are, almost by definition, people who walked into a lab. Most weren't there because they felt great. Many were there because their doctor was running annual labs on a patient who is overweight, sleep-deprived, sedentary, and pre-diabetic, which describes the average American adult. The CDC estimates that roughly 1 in 3 U.S. adults has prediabetes and the majority don't know it. About 88% of U.S. adults have at least one marker of metabolic dysfunction by some definitions. When you build a "normal" range out of that population, you are anchoring normal to a population that is, on aggregate, not healthy.
So when your fasting insulin comes back at 14 μIU/mL and your lab flags it as "in range" (because the reference range tops out somewhere around 24), what that label is really telling you is: "You're not in the top 2.5% of the people we tested." It is not telling you that your insulin is consistent with healthy metabolic function. Those are different statements.
A concierge metabolic practice uses a second framing. Instead of asking "is this value statistically common?" it asks "is this value associated with the absence of disease progression and the presence of optimal function?" Optimal ranges are tighter than conventional reference ranges, and they're built from outcomes data: longitudinal studies of people who didn't develop cardiovascular disease, didn't develop type 2 diabetes, didn't progress to chronic inflammation, didn't lose cognitive function early. The marker patterns that show up in those healthy populations become the optimal, outcomes-based range.
A fasting insulin of 14 is "normal" against the population average. It is meaningfully outside the optimal range associated with insulin sensitivity, which typically sits below 6.
Same number. Two rulers. Two different stories.
The 7 markers most commonly missed after 40
Below are seven markers we see "normal" results on in patients who clearly have something going on. None of these is a diagnosis. Each is a pattern marker that, in combination with symptoms and other lab values, has been associated in the published literature with elevated risk for the conditions listed. Pattern, not diagnosis. Talk to your clinician about what your numbers actually mean for you.
1. Fasting Insulin
Most physicals check fasting glucose. Almost none check fasting insulin in the same draw. That's a problem, because insulin is the marker that moves first. By the time fasting glucose creeps above 100, the pancreas has often been compensating with elevated insulin for years, sometimes a decade. A "normal" glucose with a quietly rising insulin is the marker pattern most commonly associated with early insulin resistance, the upstream driver of metabolic syndrome, type 2 diabetes, and a substantial portion of the cardiovascular risk that shows up in midlife.
2. HOMA-IR
HOMA-IR is a simple calculation, fasting glucose multiplied by fasting insulin and divided by 405, that turns the two numbers above into a single insulin-resistance index. It costs nothing extra to compute once both inputs are drawn. The cutoff most conventional labs use for "abnormal" is around 2.5 or higher. The cutoff associated in research literature with optimal insulin sensitivity is closer to 1.0. Patients commonly report fatigue, stubborn central adiposity, and afternoon energy crashes well before HOMA-IR crosses the conventional threshold.
3. hs-CRP
High-sensitivity C-reactive protein is a measure of low-grade systemic inflammation. Standard labs often flag it only above 3.0 mg/L, which is the level the American Heart Association historically associated with high cardiovascular risk. But the inflammation that drives accelerated aging, joint pain, brain fog, and metabolic decline often sits in the 1.0 to 3.0 range, labeled "moderate" or "normal" by conventional ranges, but meaningfully elevated against the optimal range of below 1.0. Chronic low-grade inflammation is one of the most consistently cited drivers of biological-age acceleration in the published literature.
4. ApoB
Apolipoprotein B is the protein attached to every atherogenic lipoprotein particle in your bloodstream: LDL, VLDL, IDL, Lp(a). Counting ApoB gives you a direct count of the particles capable of depositing cholesterol into an artery wall. The published literature increasingly points to ApoB as a more accurate predictor of cardiovascular event risk than LDL-C alone, because two people can have identical LDL-C and very different ApoB counts. Most annual physicals do not include ApoB. When it's drawn, the value flagged "in range" by a conventional lab may still sit well outside the optimal range associated with low cardiovascular event rates.
5. Homocysteine
Homocysteine is an amino acid that rises when B-vitamin pathways (folate, B12, B6) are functioning poorly. Elevated homocysteine has been associated in the published literature with cardiovascular risk, cognitive decline, and depression. Standard labs commonly flag it above 15 μmol/L. The optimal range associated with healthy outcomes data sits closer to below 7. Patients with values in the 8 to 14 range are routinely told their homocysteine is "normal," when in fact it sits in a band associated with measurable risk.
6. Free Testosterone
Total testosterone is what most physicals draw if they draw testosterone at all. But total testosterone is largely bound to SHBG and albumin and is not the bioavailable fraction. Free testosterone, the unbound portion that actually reaches tissue receptors, is the more functionally meaningful number for energy, mood, recovery, libido, body composition, and cognition. Free testosterone routinely sits in the conventional "normal" range even when patients are symptomatic, because the conventional range was built from a population that includes a large number of older men with age-related decline already underway.
7. DHEA-S
DHEA-S is an adrenal hormone that serves as a precursor for downstream sex hormones and is one of the more sensitive markers of HPA-axis health and biological aging. It declines steadily with age in the general population, so the conventional reference range widens dramatically as the patient gets older, which means a 50-year-old with a DHEA-S level appropriate for a 75-year-old will still be flagged "in range." Symptoms commonly reported in patients with low-for-age DHEA-S include flat affect, poor stress tolerance, reduced libido, and slow recovery from physical or mental load.
What to do about it
If you've recognized yourself in any of the above, three reasonable next steps:
1. Bring this list to your existing doctor. A reasonable primary care physician will run any of these markers if you ask for them by name. Ask specifically for: fasting insulin, hs-CRP, ApoB, homocysteine, and free testosterone (DHEA-S optional). Most labs can run them on the same draw. Some insurance plans will cover them. If your physician declines to run them, ask why. The answer is often "they weren't in the standard panel" rather than "they aren't useful."
2. Have the extended markers ordered and interpreted by a licensed clinician. Ask a licensed clinician to order the extended panel and, just as importantly, to interpret it with you. Raw numbers on their own are easy to misread. What turns them into something useful is a clinician who reads the pattern across markers against optimal, outcomes-based ranges and explains what it means for your specific situation, not just whether each value happens to sit inside a conventional reference range.
3. Use a concierge metabolic practice. A concierge metabolic practice runs the extended panel, scores it against optimized clinical reference ranges, looks for the pattern across markers (because no single marker tells the story alone), and pairs the read with a clinical consultation. This is the model 1836 Wellness uses: a 125-marker panel across 12 health domains, scored against optimized clinical reference ranges, with a 45-minute Nurse Practitioner consultation included. We launch in Texas; expansion is on the 2027 roadmap.
Whichever path you choose, the core insight is the same: don't accept "normal" as an answer when your body is telling you otherwise. The labs aren't lying. The ruler is the wrong ruler.
About the author
Stephen Myshak is the Founder & CEO of 1836 Wellness, a Houston-based concierge metabolic medicine practice serving executive professionals across Texas. He built the 1836 protocol engine and 125-marker panel after eight months of optimizing his own metabolic health using comprehensive blood work and physician-supervised protocols, work that reversed his pre-diabetic insulin pattern and reduced his biological age. 1836 Wellness operates as a cash-pay Management Services Organization under Texas Corporate Practice of Medicine doctrine.
Final disclaimer. This article is educational only. It is not medical advice, not a diagnosis, and does not create a doctor-patient relationship between you and the author, 1836 Wellness, or any clinician affiliated with 1836 Wellness. Reference ranges and optimal ranges cited above are illustrative of clinical literature on optimal reference ranges and may differ from the ranges used by your laboratory. Decisions about your health, medications, supplements, and lab testing should be made in consultation with a clinician licensed in your state who knows your full medical history. Individual results vary.
Ready to see the full 125-marker picture? Learn about the clinician-ordered Precision Diagnostic, the first step of care at 1836 Wellness.